A new 4D-QSAR approach has been considered. For all investigated molecules the 3D structural models have been created and the set of conformers (fourth dimension) have been used. Each conformer is represented as a system of different simplexes (tetratomic fragments of fixed structure, chirality and symmetry).
Prevention and treatment of oncologic diseases and viral pathology are the top problems. The above problems are interdependent, since oncogenicity of some viruses (including adenoviruses and viruses of the herpes group) has been established. We have shown that the well-known medicinal agent e-aminocapronic acid, which decreases experimental tumours growth and inhibits metastasis dissemination, has the wide spectrum of antiviral activity including anti-influenza, antiadenoviral and antiherpetic actions [1] [2] [3] . New type of MCP-macrocyclic Schiff bases and their analogues that contain different structural fragments are very promising. We have established that some of them have anticancer and/or antiviral activity [4] [5] [6] .
The structure-anticancer activity relationship of MCP within the topologic model was analyzed [4, 7] . The good agreement between observed and predicted values of activity against some cell cultures was observed for regression models. Thus, even within the simple topologic model it is possible to detect some patterns of relationship between structure of MCP and its activity. Assuming that more adequate QSAR models, taking into account a spatial structure of molecules and their conformational variety, should give more reliable results, we used a novel 4D QSAR approach, based on simplex representation of molecular structure. Anticancer activity of investigated compounds was tested in vitro at the National Cancer Institute (Bethesda, U.S.A.). The panel includes 60 cell lines of the following 9 human malignant tumors: leukemia, CNS cancer, prostate cancer, breast cancer, melanoma, non-small cell lung cancer, colon cancer, ovarian cancer, renal cancer.
MATERIALS AND METHODS

Structures
The compounds were tested at 5 concentrations, resulting from a series of 10-fold dilutions ( reflected suppression of viral replication in "experimental", as compared to "control" samples. Antiherpetic and antiadenoviral actions of investigated compounds were studied using cytomorphological method, based on calculation of the number of infected cells that contained intranuclear viral DNA inclusions [9] . The inclusions were revealed by the luminescent microscopy method. A scheme of an experiment allowing determination of antiherpes activity was as follows. 
RESULTS AND DISCUSSION
4D QSAR approach, based on simplex representation of molecular structure
In the present work a new 4D-QSAR approach has been considered. For all investigated molecules the 3D structural models have been created and sets of conformers (fourth dimension) [10] have been used. Each conformer is represented as a system of different simplexes (tetratomic fragments of fixed structure, chirality and symmetry) (see Fig. 2 ). An example is presented on Scheme 1.
The simplex representation of molecular structure for biologically active substances allows unifying the description of spatial structure of compounds with saving of the complete stereochemical information [11] [12] [13] . It enables to determine easily common fragments of spatial structure both promoting given biological activity and interfering with it. Thus, molecular structure descriptors in such a model are simplexes (fixed topology and stereochemical configuration) and their various combinations. The molecular design of compounds with the given level of activity is possible by means of generating of the allowed combinations of such types simplexes, which determine investigated property.
The developed approach has not the limitations of CoMFA (comparative molecular field analysis) [14] . In the CoMFA only single fixed conformer is considered for each compound and a choice of such a conformer is often accidental. Moreover, in CoMFA there is a problem of optimal alignment of a set of considered molecules.
The approach developed in this work is similar to HQSAR (holographic QSAR) [15] but has none of its restrictions, connected with only topological representation of molecular structure and lacks ambiguity of descriptors formation when procedure of hashing of molecular holograms is realized.
Simplexes as descriptors of molecular structure
For any molecule there are 11 base types of molecular simplexes with all possible variants Vol. 49 Anticancer and antiviral activity for macrocyclic pyridinophanes 161
of atoms bonding in a simplex. The molecular graphs of the base types of simplexes and respective examples of molecular fragments are represented in Table_1. It is possible to differentiate all simplexes to right (R), left (L), symmetrical achiral (S), plane achiral (P) (see Scheme 2) . Stereochemical configuration of simplexes is defined by modified Kahn-Ingold-Prelog rules [12] .
The structure of each simplex in molecule has been determined, with differences in atom and bond types considered. All atoms in a simplex are differentiated, based on the following characteristics: 1) element; 2) partial charge; 3) lipophility; 4) atomic refraction; 5) electronegativity of atom; 6) donor/acceptor of hydrogen in H-bond; etc.
Based on characteristics, expressed by real values (Nos. 2-5 in the list), preliminary division into a definite discrete number of atom groups, characterized by different ranges of those values, is made. 1 Chemical bonds are differentiated by its nature: single, double, triple, aromatic.
The subsequent examples (see Fig. 2 ) demonstrate different systems of the representation of molecules as simplex sets. Thus molecule of acetic acid can be represented as a set of 13 simplexes (3 right, 3 left, 2 symmetrical, 5 plane). The differentiation of atom by element gives 7 types of simplexes, but differentiation of atom by charge gives only 4 types of simplexes.
In the proposed model a number of simplexes of specific type is a descriptor of the molecular structure.
Descriptors calculation in 4D QSAR models
In the 4D QSAR models each molecular structure parameter (D, descriptor) is calculated by summing products of descriptor value for each conformer (D k ) 2 and probability of the corresponding conformer (P k ).
where N is the number of conformers being considered, D k is the descriptor value for conformer k.
As it is well known [16] , a probability of conformation P k is defined by its energy: where E i , E k is the energy of conformations i and k. The conformers are analyzed within energy band of 5-7 kcal/mol.
An example of descriptors calculation in 4D
QSAR has been demonstrated on Fig. 3 . The calculation of descriptor value for one of all possible simplexes of alanine has been shown. Thus, 4D QSAR procedure consists of the following stages: 1. Formation of training set. 2. Total conformational analysis of each compound and choice of more stable conformers within specified energy diapason (see Fig. 3 ). 3. Fragmentation of each conformer into simplexes. Identification of type of each simplex and defining its stereochemical configuration (see Fig. 2 ). 4. Descriptor value calculation for each concrete type of simplex, taking into account probability of its realization in a given compound (see Fig. 3 ).
5. Choice of significant structural parameters (descriptors) and QSAR analysis using statistical methods such as regression analysis, PLS (partial least squares), neural networks, etc. 6. Verification of QSAR models using leaveone-out cross-validation procedure and test set. 7. Off-experimental screening of novel compounds. Molecular design of effective agents.
It should be noted that stages 1, 5, 6 and 7, are obligatory for any QSAR research.
Results of the QSAR modeling
As compared to the previously used QSAR approaches, based on topologic modeling of molecular structure [4, 7] , a more adequate «structure-activity» model has been constructed with the use of a training set representative for anticancer and various types of Vol. 49 Anticancer and antiviral activity for macrocyclic pyridinophanes 163 antiviral activity and using 4D QSAR approach. It is noteworthy that the training set ( Fig. 1 ) encompasses a broad structural variety: different MCP and their acyclic analogues, and also some of synthetic nucleosides (SN) and well-known antiviral agents (ambenum, deiteforin and other) representing various classes of organic compounds. 3D QSAR approaches, such as CoMFA [14] , HASL [17] , lattice model [18] presumably cannot to be applied for this set. The main reason is that one-valued and optimal alignment of such heterogeneous structures for calculation of molecular field parameters is impossible.
As mentioned above, such limitation does not exist for simplex representation of molecular structure. In the present work the PLS method [19] was used for QSAR solutions. Quite adequate (R = 0.92-0.97) "structure-activity" models (Tables 2, 3) were obtained using PLS, by considering sets of conformers (4D-QSAR) instead of one fixed conformation. It is of note that all models have satisfactory predictive ability (CVR 2 > 0.4, Fig. 4 . Analysis of simplexes combinations allowed to select appropriate molecular fragments (Table 4) which have positive and negative influence on values of each type of considered biological activity. This information may be useful for design and direct synthesis of novel antiviral and anticancer agents. The results suggested to synthesize and investigate the following molecular structures, expected to shown different biological activities.
The results of investigation of these compounds will be discussed in separate publications. 164 V.E. Kuz'min and others 2002 3 In this tasks for description of molecular structure we used the simplexes of types 5 and 6 only. Vol. 49
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